Using both PSMA PET and mpMRI before cognitive targeted biopsy improved specificity for clinically significant prostate cancer from 54.6% to 86.3%. For men undergoing evaluation for suspected prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results